CLINICAL TYPOLOGY OF ENDOGENOUS ANXIETY DEPRESSIONS

Bulletin of fundamental and clinic medicine, 2022 №4

Subject of the article

CLINICAL TYPOLOGY OF ENDOGENOUS ANXIETY DEPRESSIONS (59-62)

Authors

Agranovsky Mark Lazarevich, Agranovsky Konstantin Markovich, Muminov Rakhimzhon Kayumzhonovich

Institution

Andijan State Medical Institute, Uzbekistan, Andijan

Abstract

Endogenous depression is an emotional disorder caused by changes in the level of hormones and neurotransmitters, manifested by a decrease in mood, inhibition of thinking and slowing down of motor activity. Among the leading symptoms are depression, loneliness, isolation, lack of positive emotions, lethargy, apathy, physical inactivity, difficulties with memorizing new information and solving intellectual tasks. In the article, clinical conversation, observation and psychological tests are used to diagnose endogenous anxiety depressions, the main method of treatment is pharmacotherapy, psychotherapeutic sessions are additionally conducted, biological methods of therapy are used, and so on. This article presents information about the clinical manifestations of endogenous anxiety depressions, their variants and typology.

Key words

depression of endogenous genesis, anxiety disorders, psychopathology, clinical typology.

Literature

  1. Александровский Ю.А. Диагностика и терапия психических расстройств у больных первичного звена медицинской помощи. Лекции для практикующих врачей. Актуальные вопросы кардиологии, неврологии и психиатрии. Здоровье человека. М.: 2017.- С.9-26.
  2. Ротштейн В.Г., Богдан М.Н., Результаты опроса больных, страдающих аффективными расстройствами (европейское исследование). Журнал неврологии и психиатрии. 2013.-№10,- С.54-59.
  3. Филатова Е.Г., Ковров Т.В., Башанова Е.Г., Яковлев О.Н., Посохов С.И. Ремерон в неврологической практике. Психиатрия и психофармакотерапия. 2013.- №1.- С. 68.
  4. Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatr Res 2005;39:43-53.
  5. Thompson C. Onset of action of antidepressants: results of different analyses. Hum Psychopharmacol Clin Exp 2012; 17: S27-32.
  6. Watson D., Weber K., Assenheimer J.S. et al: Testing a tripartite model: I. evaluating the convergent and discriminant validity of anxiety and depression symptom subscales. Journal of Abnormal Psychology. 2005.-1: 3-14

ARTICLES